Adenilson Souza Costa, 47, and his employees in protective clothing carry a coffin in the Vila Formosa Cemetery amid the Coronavirus Pandemic (COVID-19) on May 18, 2020 in Sao Paulo, Brazil.
Alexandre Schneider | Getty Images
The corona virus has now killed more than 500,000 people around the world as the number of confirmed infections exceeded 10 million, according to Johns Hopkins University.
The United States, according to Hopkins, accounts for more than 20% of all deaths caused by Covid-19, more than any other country in the world, followed by Brazil, the United Kingdom, Italy and France. However, country comparisons of the death toll are difficult due to different reporting methods.
Earlier this month, the World Health Organization warned that the pandemic is accelerating on a global scale, adding that the outbreak has entered a "new and dangerous phase".
"Many people understandably are tired of being at home. Countries understandably strive to open up their societies and economies. But the virus is still spreading quickly. It is still fatal and most people are still vulnerable," said WHO Director General Tedros Adhanom Ghebreyesus said on June 19.
According to the World Health Organization, the death toll at Covid-19 was over 400,000 on June 8 and over 300,000 on May 16.
There are no drugs approved by the United States Food and Drug Administration for the treatment of Covid-19. However, researchers have seen some success in accelerating recovery in patients with Gileads remdesivir. Earlier this month, researchers in the UK found that dexamethasone, a cheap and widely used steroid, reduced the risk of death for Covid 19 patients with ventilators and a fifth for patients with additional oxygen.
According to the WHO, 16 vaccine candidates are currently in clinical trials. AstraZeneca's potential vaccine, which is being developed in collaboration with Oxford University researchers, is currently the most under development, said WHO chief scientist Dr. Soumya Swaminathan on Friday at a virtual press conference. She added that the candidate of the US biotech company Moderna is not far behind.
WHO also called on Friday for additional funding of $ 27.9 billion for the ACT Accelerator, a public-private partnership that includes WHO research tools to fight Covid-19. Funding would help accelerate drug and vaccine development and prevent further infections, deaths, and economic disruptions, according to WHO.
The virus is still spreading rapidly in many countries in America, said Mike Ryan, executive director of the WHO emergency program, last week.
"And as such, the trip for them is unfortunately the pandemic for many countries in America has not peaked," he said.